Becton Dickinson and Co
LSE:0R19
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Becton Dickinson and Co (0R19) under the Base Case is 202.7539 USD per share.
Compared with the current market price of 212.3093 USD, the stock appears
Overvalued by 5% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Becton Dickinson and Does
Becton Dickinson, better known as BD, makes medical devices and supplies used in hospitals, labs, doctor offices, and by patients at home. Its core products include needles, syringes, catheters, blood collection systems, infusion and medication-delivery equipment, and diagnostic tools that help identify infections and other conditions. The company sits deep in the healthcare supply chain, where its products are used every day and are often needed in large, steady volumes.
- Headquarters
- United States of America US
- Employees
- 72 000
- IPO date
- Sep 25, 1963
Becton Dickinson and has a narrow economic moat
Replacing BD’s medication systems means changing hospital software connections, retraining staff and checking that care can continue safely, making a cheaper rival less attractive. Patents on selected medical-device designs also prevent competitors from copying protected features directly, although these protections do not cover every product BD sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Becton Dickinson and Co
Earnings Waterfall
Becton Dickinson and Co
What is the Intrinsic Value of one 0R19 stock?
The intrinsic value for Becton Dickinson and Co (0R19) under the Base Case is 202.7539 USD.
Is 0R19 stock undervalued or overvalued?
Compared with the current market price of 212.3093 USD, the stock appears Overvalued by 5% .
